213 related articles for article (PubMed ID: 17187081)
21. Beneficial effects of sub-chronic activation of glucagon-like peptide-1 (GLP-1) receptors on deterioration of glucose homeostasis and insulin secretion in aging mice.
Irwin N; McClean PL; Harriott P; Flatt PR
Exp Gerontol; 2007 Apr; 42(4):296-300. PubMed ID: 17184947
[TBL] [Abstract][Full Text] [Related]
22. TCF7 is not essential for glucose homeostasis in mice.
Kaur KD; Wong CK; Baggio LL; Beaudry JL; Fuchs S; Panaro BL; Matthews D; Cao X; Drucker DJ
Mol Metab; 2021 Jun; 48():101213. PubMed ID: 33741532
[TBL] [Abstract][Full Text] [Related]
23. Increased insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors.
Tura A; Bizzotto R; Yamada Y; Seino Y; Pacini G; Ahrén B
Am J Physiol Regul Integr Comp Physiol; 2018 May; 314(5):R639-R646. PubMed ID: 29351421
[TBL] [Abstract][Full Text] [Related]
24. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
Gelling RW; Du XQ; Dichmann DS; Romer J; Huang H; Cui L; Obici S; Tang B; Holst JJ; Fledelius C; Johansen PB; Rossetti L; Jelicks LA; Serup P; Nishimura E; Charron MJ
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1438-43. PubMed ID: 12552113
[TBL] [Abstract][Full Text] [Related]
25. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.
Ayala JE; Bracy DP; James FD; Julien BM; Wasserman DH; Drucker DJ
Endocrinology; 2009 Mar; 150(3):1155-64. PubMed ID: 19008308
[TBL] [Abstract][Full Text] [Related]
26. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance.
Conarello SL; Li Z; Ronan J; Roy RS; Zhu L; Jiang G; Liu F; Woods J; Zycband E; Moller DE; Thornberry NA; Zhang BB
Proc Natl Acad Sci U S A; 2003 May; 100(11):6825-30. PubMed ID: 12748388
[TBL] [Abstract][Full Text] [Related]
27. Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice.
Scrocchi LA; Drucker DJ
Endocrinology; 1998 Jul; 139(7):3127-32. PubMed ID: 9645685
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity.
Lockie SH
J Neuroendocrinol; 2013 Jul; 25(7):597-604. PubMed ID: 23590331
[TBL] [Abstract][Full Text] [Related]
29. Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.
Mieczkowska A; Mansur S; Bouvard B; Flatt PR; Thorens B; Irwin N; Chappard D; Mabilleau G
Osteoporos Int; 2015 Jan; 26(1):209-18. PubMed ID: 25127672
[TBL] [Abstract][Full Text] [Related]
30. Reduced Incretin Receptor Trafficking upon Activation Enhances Glycemic Control and Reverses Obesity in Diet-Induced Obese Mice.
Bauri R; Bele S; Edelli J; Reddy NC; Kurukuti S; Devasia T; Ibrahim A; Rai V; Mitra P
Am J Physiol Cell Physiol; 2024 May; ():. PubMed ID: 38738303
[TBL] [Abstract][Full Text] [Related]
31. Islet development: When glucagon's gone.
Gittes GK; Fisher BR
Endocrinology; 2006 Sep; 147(9):3993-4. PubMed ID: 16912233
[No Abstract] [Full Text] [Related]
32. Incretin-like effects of small molecule trace amine-associated receptor 1 agonists.
Raab S; Wang H; Uhles S; Cole N; Alvarez-Sanchez R; Künnecke B; Ullmer C; Matile H; Bedoucha M; Norcross RD; Ottaway-Parker N; Perez-Tilve D; Conde Knape K; Tschöp MH; Hoener MC; Sewing S
Mol Metab; 2016 Jan; 5(1):47-56. PubMed ID: 26844206
[TBL] [Abstract][Full Text] [Related]
33. Hepatic and Extrahepatic Insulin Clearance in Mice with Double Deletion of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Receptors.
Morettini M; Piersanti A; Burattini L; Pacini G; Göbl C; Ahrén B; Tura A
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440177
[TBL] [Abstract][Full Text] [Related]
34. Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress.
Fadzeyeva E; Locatelli CAA; Trzaskalski NA; Nguyen MA; Capozzi ME; Vulesevic B; Morrow NM; Ghorbani P; Hanson AA; Lorenzen-Schmidt I; Doyle MA; Seymour R; Varin EM; Fullerton MD; Campbell JE; Mulvihill EE
iScience; 2023 May; 26(5):106748. PubMed ID: 37216093
[TBL] [Abstract][Full Text] [Related]
35. [Pancreatic beta cell and incretin receptor].
Takahara M; Kaneto H
Nihon Rinsho; 2012 May; 70 Suppl 3():139-44. PubMed ID: 22768511
[No Abstract] [Full Text] [Related]
36. Exocrine pancreas hyperplasia without dysplasia in glucagon receptor knockout mice.
Yu R; Nissen NN; Dhall D
Pancreas; 2014 Jan; 43(1):143-5. PubMed ID: 24326371
[No Abstract] [Full Text] [Related]
37. Novel incretin receptor antibodies combat weight gain.
Crunkhorn S
Nat Rev Drug Discov; 2019 Feb; 18(2):95. PubMed ID: 30710135
[No Abstract] [Full Text] [Related]
38. Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.
Sisley S; Gutierrez-Aguilar R; Scott M; D'Alessio DA; Sandoval DA; Seeley RJ
J Clin Invest; 2014 Jun; 124(6):2456-63. PubMed ID: 24762441
[TBL] [Abstract][Full Text] [Related]
39. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
[TBL] [Abstract][Full Text] [Related]
40. Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.
Chen S; Okahara F; Osaki N; Shimotoyodome A
Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E414-25. PubMed ID: 25537494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
